Reversal of Edoxaban Induced Anticoagulation
1 clinical trials · Condition
◉ Watch Reversal of Edoxaban Induced Anticoagulation
| Record | Firm | Date |
|---|---|---|
| Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban (NCT01826266) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2013-07-01 |
Track Reversal of Edoxaban Induced Anticoagulation automatically
Every clearance here is in the API, with alerts when new ones post.